High-Growth Two-Location Medical Oncology Practice | Southwestern U.S. | Infusion & In-House Pharmacy
Seller Overview:
Seller States: This offering represents the opportunity to acquire a well-established, high-growth medical oncology practice with two locations in separate Southwestern states, each serving a distinct patient population. The primary location has operated for approximately 18 years and includes an in-house pharmacy, infusion suite, and Lab-corp, while the second location was established approximately four years ago to expand into an additional market.
Both offices are fully staffed and operate five days per week, with Nurse Practitioners, Physician Assistants, and Medical Assistants ensuring continuity of care and an uninterrupted service. The practice also maintains an experienced in-house billing team.
The seller, the sole oncologist, currently maintains a progressive clinical schedule across both locations. Significant growth opportunities exist through the future addition of provider, expanded clinic hours, and increased infusion and pharmacy volume.
Revenue is primarily derived from infusion services (~80%), including chemotherapy, and specialty pharmacy with approximately 14% generated from Evaluation & Management visits. Additional revenue streams include in-office procedures such as bone marrow biopsies. The in-house pharmacy operates at both primary locations (inventory not included in the sale).
The practice participates with Medicare and most major commercial insurers, providing a diversified and stable reimbursement base.
Growth Opportunities:
• Expand clinical capacity through additional physicians and/or APPs
• Increase infusion utilization and in-house pharmacy revenue
• Further penetrate two distinct and underserved regional markets
• Addition of imaging services and radiation therapy
Operations & Transition:
• Tenured, experienced clinical and administrative teams in place at both locations
• Established referral relationships and strong reputations in each community
• Efficient, scalable workflows to support a seamless ownership transition
• Seller available for 1–2 years to assist with transition, payer relationships, and growth initiatives
Services Provided:
• Medical oncology
• Hematology
• Chemotherapy and specialty infusions
• Immunotherapy
• Bone marrow biopsies
• Evaluation & Management (E&M) services
• Clinical research (included in this transaction) has increased from four (4) studies in 2025 to eleven (11) in 2026.
Investment Highlights:
• 2025 Gross Revenue of $19M+ with $2.17M+/- SDE & $1.62M+/-Adjusted EBITDA. 2026 is trending substantially higher than 2025.
• Two fully operational, modern facilities in separate Southwestern states
• High-margin, infusion-driven revenue model with ancillary pharmacy income
• Fully staffed, turnkey platform with capacity for provider expansion
• Significant upside through adding a full-time oncologist, expanding clinic hours, and increasing infusion and pharmacy volume
Additional Information:
Serious inquiries only. This medical practice operates in a regulated industry. Prospective buyers should have relevant industry experience and understand the applicable licensing and regulatory requirements.
Execution of a Non-Disclosure Agreement (NDA) and proof of funds are required prior to the release of confidential information.
One Southwest practice location is represented by First Choice Business Brokers Phoenix #213 #101, Dr. Fernando Acosta, Owner/Business Broker/Agent (AZ R.E. Lic.# LC68988001 | SA691260000) and Dr. Leilani Felix- Acosta, Owner/Business Broker (AZ R.E. Lic. #LC68988001 | SA693611000. The other Southwest practice location is represented by a separate licensed brokerage in that state.
Número de listado:
Categoría:
Ubicación:
VENDIDO
Información financiera:
Ingresos brutos:
Precio listado:
Ingreso neto ajustado total:
Equipos / Accesorios:
Año Establecido:
Ubicación General:
Hello World
Corredores comerciales de primera elección
La información contenida en este documento se recibió del Vendedor y se considera confiable pero no está garantizada. First Choice Business Brokers (FCBB) ha confiado en que el Vendedor proporcione los detalles anteriores y NO ha verificado esta información. FCBB no es responsable y NO garantiza ninguna declaración, proyección o información proporcionada por el Vendedor. El Usuario/Comprador será el único responsable de la verificación de las ganancias y operación comercial del Vendedor. Al aceptar este documento, el Comprador/Usuario acepta que toda la información aquí contenida es estrictamente confidencial y no será revelada a ninguna otra parte sin autorización previa por escrito. El Comprador/Usuario confirma y comprende que FCBB NO ha realizado una investigación independiente del negocio o las cifras citadas en este documento. FCBB recomienda encarecidamente que un Comprador busque asesoramiento legal y contable antes de comprar un Negocio. Cualquier cambio en la información anterior requiere la aprobación por escrito tanto del Vendedor como de FCBB. Cualquier cambio realizado en este documento sin la aprobación de FCBB y del Vendedor no es válido.
La información contenida en este listado ha sido proporcionada por el vendedor o representante comercial mencionado anteriormente. First Choice Business Broker no tiene participación en la venta de este negocio, no ha verificado de forma independiente ninguna información sobre el negocio y no asume ninguna responsabilidad por su exactitud o integridad.
Lea los Términos de uso de First Choice Business Broker antes de responder a cualquier anuncio.
Nombre de la empresa
Ubicación: las vegas
High-Growth Two-Location Medical Oncology Practice | Southwestern U.S. | Infusion & In-House Pharmacy
Seller Overview:
Seller States: This offering represents the opportunity to acquire a well-established, high-growth medical oncology practice with two locations in separate Southwestern states, each serving a distinct patient population. The primary location has operated for approximately 18 years and includes an in-house pharmacy, infusion suite, and Lab-corp, while the second location was established approximately four years ago to expand into an additional market.
Both offices are fully staffed and operate five days per week, with Nurse Practitioners, Physician Assistants, and Medical Assistants ensuring continuity of care and an uninterrupted service. The practice also maintains an experienced in-house billing team.
The seller, the sole oncologist, currently maintains a progressive clinical schedule across both locations. Significant growth opportunities exist through the future addition of provider, expanded clinic hours, and increased infusion and pharmacy volume.
Revenue is primarily derived from infusion services (~80%), including chemotherapy, and specialty pharmacy with approximately 14% generated from Evaluation & Management visits. Additional revenue streams include in-office procedures such as bone marrow biopsies. The in-house pharmacy operates at both primary locations (inventory not included in the sale).
The practice participates with Medicare and most major commercial insurers, providing a diversified and stable reimbursement base.
Growth Opportunities:
• Expand clinical capacity through additional physicians and/or APPs
• Increase infusion utilization and in-house pharmacy revenue
• Further penetrate two distinct and underserved regional markets
• Addition of imaging services and radiation therapy
Operations & Transition:
• Tenured, experienced clinical and administrative teams in place at both locations
• Established referral relationships and strong reputations in each community
• Efficient, scalable workflows to support a seamless ownership transition
• Seller available for 1–2 years to assist with transition, payer relationships, and growth initiatives
Services Provided:
• Medical oncology
• Hematology
• Chemotherapy and specialty infusions
• Immunotherapy
• Bone marrow biopsies
• Evaluation & Management (E&M) services
• Clinical research (included in this transaction) has increased from four (4) studies in 2025 to eleven (11) in 2026.
Investment Highlights:
• 2025 Gross Revenue of $19M+ with $2.17M+/- SDE & $1.62M+/-Adjusted EBITDA. 2026 is trending substantially higher than 2025.
• Two fully operational, modern facilities in separate Southwestern states
• High-margin, infusion-driven revenue model with ancillary pharmacy income
• Fully staffed, turnkey platform with capacity for provider expansion
• Significant upside through adding a full-time oncologist, expanding clinic hours, and increasing infusion and pharmacy volume
Additional Information:
Serious inquiries only. This medical practice operates in a regulated industry. Prospective buyers should have relevant industry experience and understand the applicable licensing and regulatory requirements.
Execution of a Non-Disclosure Agreement (NDA) and proof of funds are required prior to the release of confidential information.
One Southwest practice location is represented by First Choice Business Brokers Phoenix #213 #101, Dr. Fernando Acosta, Owner/Business Broker/Agent (AZ R.E. Lic.# LC68988001 | SA691260000) and Dr. Leilani Felix- Acosta, Owner/Business Broker (AZ R.E. Lic. #LC68988001 | SA693611000. The other Southwest practice location is represented by a separate licensed brokerage in that state.
Número de listado:
Categoría:
Ubicación:
Ubicación del negocio
Ciro 'Vic' Coppola
Oficina: (702) 368-2500 | Celular: (725) 233-3333
Licencia #: BS.0146004
Información financiera:
Ingresos brutos
Ventas brutas formateadas
Precio listado:
Precio de listado formateado
Información de arrendamiento:
Pies cuadrados:
Pies cuadrados
Renta total:
FormateadoTotalRent
Vencimiento del arrendamiento:
Fin del contrato de arrendamiento
Opciones de arrendamiento:
Opciones
Información de activos:
Mejoras arrendatarias:
Mejoras en el arrendamiento formateado
Equipos / Accesorios:
Accesorios de equipo formateado
Información adicional:
Empleados de tiempo completo:
Empleados de tiempo completo
Empleados a tiempo parcial:
0
Periodo de entrenamiento:
Periodo de formación
Razón de venta:
Razón de venta
Corredores comerciales de primera elección
La información contenida en este documento se recibió del Vendedor y se considera confiable pero no está garantizada. First Choice Business Brokers (FCBB) ha confiado en que el Vendedor proporcione los detalles anteriores y NO ha verificado esta información. FCBB no es responsable y NO garantiza ninguna declaración, proyección o información proporcionada por el Vendedor. El Usuario/Comprador será el único responsable de la verificación de las ganancias y operación comercial del Vendedor. Al aceptar este documento, el Comprador/Usuario acepta que toda la información aquí contenida es estrictamente confidencial y no será revelada a ninguna otra parte sin autorización previa por escrito. El Comprador/Usuario confirma y comprende que FCBB NO ha realizado una investigación independiente del negocio o las cifras citadas en este documento. FCBB recomienda encarecidamente que un Comprador busque asesoramiento legal y contable antes de comprar un Negocio. Cualquier cambio en la información anterior requiere la aprobación por escrito tanto del Vendedor como de FCBB. Cualquier cambio realizado en este documento sin la aprobación de FCBB y del Vendedor no es válido.
La información contenida en este listado ha sido proporcionada por el vendedor o representante comercial mencionado anteriormente. First Choice Business Broker no tiene participación en la venta de este negocio, no ha verificado de forma independiente ninguna información sobre el negocio y no asume ninguna responsabilidad por su exactitud o integridad.
Lea los Términos de uso de First Choice Business Broker antes de responder a cualquier anuncio.
